Topical Insulin for Glaucoma (TING2)
Topical Insulin for Glaucoma (TING2)
Not yet recruiting · NCT07619482 · Registry updated 2026-06-02Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Topical Insulin for Glaucoma (TING2) | Glaucoma, Primary Open Angle, exfoliation glaucoma, exfoliation syndrome, eye disorder, glaucoma, iris disorder, low tension glaucoma, ocular hypertension, open-angle glaucoma, optic nerve disorder, uveal disorder | Not yet recruiting | Phase 1 / Phase 2 | 2026-06-02 | NCT07619482 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Stanford University | 620 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Byers Eye Institute at Stanford University | Palo Alto | United States | 11 |